<DOC>
	<DOCNO>NCT02667210</DOCNO>
	<brief_summary>To assess whether percentage patient behavior suggestive misuse , diversion , abuse and/or addiction describe medical record increase across pre-defined category increase doctor/pharmacy shopping behavior .</brief_summary>
	<brief_title>Study Eval Relation Btw Doctor/Pharmacy Shopping &amp; Outcomes Misuse , Diversion , Abuse , Addiction Med Rec Review</brief_title>
	<detailed_description>Based review literature , Food Drug Administration ( FDA ) conclude data need regard serious risk misuse , abuse , addiction , overdose , death associate long-term use extend release/long acting ( ER/LA ) opioid analgesic . Thus , FDA require ER/LA opioid analgesic drug sponsor conduct post-marketing study assess risk . The four observational post-marketing requirement ( PMR ) study label Study # 2065-1 , Study # 2065-2 , Study # 2065-3 , Study # 2065-4 . The objective PMR Study # 2065-4 define validate doctor/pharmacy shop outcome suggestive misuse , diversion , abuse and/or addiction . Study # 2065-4 consists three sub-studies , Study 4A , Study 4B , Study 4C . In current study ( # 2065-4 sub-study , Study 4C ) , association doctor/pharmacy shop behavior misuse , diversion , abuse and/or addiction assess review medical chart sample patient within specific category priori define doctor/pharmacy shopping . The four category doctor/pharmacy shop behavior identify define Study 4A apply Study 4C . The medical chart rich source information patient 's medical condition behavior suggestive misuse abuse . Medical record review behavior suggestive misuse abuse patient chronic pain discriminate patient without opioid use disorder . Therefore , Study 4C design utilize insurance/health plan database ( HealthCore Integrated Research Database [ HIRD ] ) access medical record , evaluate association priori define category doctor/pharmacy shop behavior suggestive misuse , diversion , abuse and/or addiction .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>1 . Patients 18 year old date first IR ER/LA opioid dispense 2012 2 . Patients least two dispensings IR ER/LA opioid . The first dispensings occur 2012 additional dispense within 18 month first . 3 . Continuous , fully insured enrollment medical pharmacy eligibility health plan include HealthCore Integrated Research Database ( HIRD ) least six month prior start followup period . 4 . Patients continuous enrollment followup period 18 month 1 . Patients classify one four priori define doctor/pharmacy shopping category 2 . Patients medical record access 3 . Patients known history abuse identify administrative claim data exclude HealthCore permit request medical record .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>